• Views: in the last
  • 31Week
  • 15Month
  • 143Total


  • NJ A4094
  • Requires epinephrine auto-injectors to be packaged and sold as single units.
Introduced
(9/15/2016)
In Committee
(11/3/2016)
Crossed Over
(10/20/2016)
PassedSignedDead/Failed/Vetoed
2016-2017 Regular Session
This act would prohibit a business that is engaged in the manufacture or distribution of epinephrine auto-injectors for dispensing to patients in this State from marketing or distributing epinephrine auto-injectors in a fashion that requires a patient to purchase multiple epinephrine auto-injectors in a single transaction. A business that, on the effective date of this act, is authorized by the federal Food and Drug Administration to manufacture or distribute epinephrine auto-injectors in packaging containing more than a single epinephrine auto-injector would be required to immediately apply for approval to manufacture or distribute epinephrine auto-injectors in packaging containing a single epinephrine auto-injector. Currently, the dominant epinephrine auto-injector product, EpiPen, is sold to consumers only in a package that includes two devices. A single unit package was discontinued in 2011. The bill would require the manufacturer of EpiPen, Mylan, to again make these products available in single unit packages.
2nd Reading in the Assembly, Health and Senior Services, Health, Human Services and Senior Citizens, Passed Assembly
Received in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee  (on 11/3/2016)
 
 

Date Chamber Action Description
11/3/2016 S Received in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
10/20/2016 A Passed by the Assembly (72-0-0)
10/6/2016 A Reported out of Assembly Committee, 2nd Reading
10/6/2016 Assembly Health and Senior Services Hearing (10:00 10/6/2016 Committee Room 11, 4th Floor)
9/15/2016 A Introduced, Referred to Assembly Health and Senior Services Committee
Date Motion Yea Nay Other
Detail 10/20/2016 Assembly Floor: Third Reading - Final Passage 72 0 8
Detail 10/6/2016 Assembly Health and Senior Services Committee: Reported Favorably 11 0 2